Covered recipient · General Payments record
MUHAMMAD ARSHAD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,144.17
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.70 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $119.58 | 4 |
| ABBVIE INC. | $111.95 | 4 |
| Nevro Corp. | $98.57 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $26.65 | 1 |
| EISAI INC. | $24.99 | 1 |
| LivaNova USA, Inc. | $20.32 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.71 | 1 |
| Grifols USA, LLC | $15.90 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.79 | 1 |
| Aucta Pharmaceuticals, Inc. | $12.24 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.36 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103243139 | CMS |
| ABBVIE INC. | $26.92 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103243141 | CMS |
| ABBVIE INC. | $33.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103243143 | CMS |
| ABBVIE INC. | $29.09 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103243145 | CMS |
| Aucta Pharmaceuticals, Inc. | $6.75 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905172 | CMS |
| Aucta Pharmaceuticals, Inc. | $5.49 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905466 | CMS |
| Boston Scientific Corporation | $26.65 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092602526 | CMS |
| Eisai Inc. | $24.99 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110768375 | CMS |
| Grifols USA, LLC | $15.90 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124717122 | CMS |
| LivaNova USA, Inc. | $20.32 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152801693 | CMS |
| Nevro Corp. | $98.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130774811 | CMS |
| Novartis Pharmaceuticals Corporation | $17.71 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086630591 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.79 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118855142 | CMS |
| UCB, Inc. | $41.11 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015280 | CMS |
| UCB, Inc. | $24.06 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015282 | CMS |
| UCB, Inc. | $21.78 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015284 | CMS |
| UCB, Inc. | $32.63 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015286 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.